bpc 157 srbija BPC-157 - 10 mg BPC-157 (Body Protection Compound) |

For 5-amino-1MQ specifically: Preclinical studies have not prominently described heart rate elevation as a dominant signal The mechanism (NNMT inhibition, NAD+ preservation) does not have the same direct cardiac implications as nuclear receptor agonism Human cardiovascular data at clinically relevant exposures are limited For physicians, the current evidence base does not support a major cardiovascular safety flag, but the limited human dataset means confident statements are premature

Lower doses (1025mg/kg in rodents) produced partial NNMT inhibition (3040%) but failed to trigger measurable metabolic shifts in energy expenditure or body composition

Potential for resistance or adaptation Whether the body adapts to NNMT inhibition over time is unknown

Research suggests benefits for inflammatory bowel conditions, gastric ulcers, esophageal damage, and gut lining integrity

This dual preservation of both NAD+ and methylation resources represents a unique mechanism among metabolic modulators, positioning 5-amino-1MQ as a bridge between energy metabolism and epigenetic regulation